Get started
Author

Pranali Ravikumar

ORCID: 0000-0003-3989-4251
Observed ORCID: 0000-0003-3989-4251
OpenAlex ID: A5035894670
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
2020 · Margaret M. Billingsley, Nathan Singh, et al. · Nano Letters · 626
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
2020 · Nathan Singh, Yong Gu Lee, et al. · Cancer Discovery · 294
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
2023 · Vera Bril, Vera Bril, et al. · The Lancet Neurology · 293
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells
2021 · Nathan Singh, Noelle V. Frey, et al. · Nature Medicine · 196
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells
2023 · Sangya Agarwal, M. Angela Aznar, et al. · Immunity · 185
Potentiating adoptive cell therapy using synthetic IL-9 receptors
2022 · Anusha Kalbasi, Mikko Siurala, et al. · Nature · 121
PDF
A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy
2020 · Shannon K. Oda, Kristin G. Anderson, et al. · The Journal of Experimental Medicine · 61
Single Chain Variable Fragment Linker Length Regulates CAR Biology and T Cell Efficacy
2019 · Nathan Singh, Noelle V. Frey, et al. · Blood · 18
Abstract 5571: Disruption of cell-intrinsic checkpoint regulator CTLA-4 in CD19 directed CAR T cells provides clinical efficacy in CLL patients
2022 · Sangya Agarwal, Angela Aznar Gomez, et al. · Cancer Research · 3
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors
2022 · Anusha Kalbasi, Mikko Siurala, et al. · Nature · 2
PDF
CAR T Cell Cytotoxicity Is Dependent on Death Receptor-Driven Apoptosis
2018 · Nathan Singh, Olga Shestova, et al. · Blood · 2
175 A Fas-4–1BB immunomodulatory fusion protein converts a pro-death to a pro-survival signal, enhancing T cell function and efficacy of adoptive cell therapy in murine models of AML and pancreatic cancer
2020 · Shannon Oda, Kristin Anderson, et al. · Regular and Young Investigator Award Abstracts · 1
Impaired tumor death receptor signaling drives resistance to CAR T cell therapy
2019 · Nathan Singh, Olga Shestova, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Cheating death: a Fas-41BB immunomodulatory fusion protein obviates a death signal to enhance T cell function and adoptive therapy targeting leukemia and solid tumors
2018 · Shannon K Oda, Kristin G Anderson, et al. · The Journal of Immunology · 1
Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKS
2026 · Nirmala Gonsalves, Nam Q. Nguyen, et al. · Gastroenterology
Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKS
2026 · Nirmala Gonsalves, Nam Q. Nguyen, et al. · Gastrointestinal Endoscopy
S891 Results From Dose Escalation Cohorts 1-6 of RESOLVE, an Ongoing Phase 1b/2a Study of EP-104GI (Long-Acting Fluticasone Propionate Injectable Suspension) for Eosinophilic Esophagitis
2025 · Amanda Malone, James Helliwell, et al. · The American Journal of Gastroenterology
Data from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
2023 · Nathan Singh, Yong Gu Lee, et al.
Table S2 from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
2023 · Nathan Singh, Yong Gu Lee, et al.
Figure S2 from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
2023 · Nathan Singh, Yong Gu Lee, et al.
Figure S1 from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
2023 · Nathan Singh, Yong Gu Lee, et al.
Figure S5 from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
2023 · Nathan Singh, Yong Gu Lee, et al.
Table S3 from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
2023 · Nathan Singh, Yong Gu Lee, et al.
Figure S3 from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
2023 · Nathan Singh, Yong Gu Lee, et al.
Figure S7 from Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
2023 · Nathan Singh, Yong Gu Lee, et al.
PDF
Works count: 43
Citation count: 1,800
H-index: 8
I10-index: 8
Year
Topic
Type